|Videos|June 17, 2014

Charles M. Perou, PhD, Discusses Genomic Signatures and Dual HER2-Targeting in Breast Cancer

Charles M. Perou, PhD, professor of genetics, pathology & laboratory medicine, UNC Lineberger Comprehensive Cancer Center, discusses a trial (CALGB 40601) presented at the 2014 ASCO Annual Meeting.

Charles M. Perou, PhD, professor of genetics, pathology & laboratory medicine, UNC Lineberger Comprehensive Cancer Center, discusses a trial (CALGB 40601) presented at the 2014 ASCO Annual Meeting that analyzed gene expression signatures in patients with HER2-positive breast cancer treated with weekly paclitaxel and trastuzumab with or without lapatinib.

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!

Charles M. Perou, PhD, Discusses Genomic Signatures and Dual HER2-Targeting in Breast Cancer

Newsletter

Related Content

Transforming HER2+ Metastatic Breast Cancer Treatment With Targeted ADC Therapy

Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy

Weekly Paclitaxel May Hold the Key to Pembrolizumab’s Success in Platinum-Resistance Ovarian Cancer

Dato-DXd Doubles Response Rates and Extends Survival in First-Line Metastatic TNBC

TAR-200 Demonstrates Strong Efficacy and Favorable Tolerability in BCG-Unresponsive NMIBC

Latest CME

The Role of the Pharmacist in Influenza Prevention for At-Risk Adults: Strategies to Enhance Immunization

Optimizing Lipid Management in Statin-Intolerant Populations: Payer Strategies for Evidence-Based Access and Risk Reduction

Targeting the Root of Autoimmunity in Generalized Myasthenia Gravis: Pharmacist Strategies for Integrating FcRn Therapies Into Specialty Practice

ASCP 2025 Satellite Symposia

Utilizing VMAT-2 Inhibitors for the Management of Tardive Dyskinesia: The Role of Long-Term Care Pharmacists

Effective Strategies to Manage Hyperglycemia When Treating with PI3K and AKT Inhibitors

New Horizons in ATTR-CM: Therapeutic Advances and Strategic Insights

AMCP Nexus 2025

Multidisciplinary Insights and Strategies for Patients Treated With PI3K and AKT Inhibitors to Prevent Hyperglycemia

Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support Insulin Pump Management (Pharmacy Technician Credit)

Collaborating Across the Continuum™: Identifying and Preventing Hepatic Encephalopathy in Long-Term Care Settings

The Latest Updates and Pharmacist Perspectives on RET Inhibitors in Non‒Small Cell Lung Cancer

The Role of Pharmacists in Pneumococcal Prevention: Strategies to Improve Vaccine Uptake

Asembia Specialty Pharmacy Day of Education 2025

Addressing Gaps in Care for Hyperkalemia With Novel Oral Potassium Binding Agents

Advancing Treatment Strategies in Extensive-Stage Small Cell Lung Cancer: Enhancing Pharmacist Competence in Therapy Selection, Administration, and Adverse Event Management

Balancing the Burden of Moderate to Severe Atopic Dermatitis in Pediatric Patients: Navigating the Use of Targeted Biologic Therapies and Caregiver Challenges

Transforming Gout Care: Navigating Barriers and Therapeutic Advances in Disease Management

Insights in Influenza Immunization: The Long-Term Care Pharmacist’s Role in Improving Health Outcomes in At-Risk Populations and Vaccine Uptake

Glucagon for Diabetes: Overcoming Barriers for Optimal Management in the Long-Term Care Setting

Managing Schizophrenia: Evidence-Based Care and Optimizing Value of New and Emerging Therapies

Directions in Oncology Pharmacy® 2025: Northeast

Best Practice Approaches for Understanding Chronic Obstructive Pulmonary Disease and Precision Medicine Treatment

Enhancing Endometrial Cancer Management: Highlights of Molecular Insights, Treatment Approaches, and Toxicity Management

How Artificial Intelligence Is Transforming Cancer Care: Essential Insights for Oncology Pharmacists

Closing Gaps in CLL Care: Managed Care Insights and Strategies

Exploring the Role of Glucagon Like Peptide Receptor 1 Agonists (GLP-1RA) in the Treatment of Obesity (Pharmacist Credit)

Enhancing Safety in Cancer Care: Expert Guidance on Toxicity Management of HER2, TROP2, and HER3-Targeted Antibody-Drug Conjugates

Patient Safety and Reporting Errors: A Guide for Pharmacists and Technicians (Pharmacy Technician Credit)

Patient Safety and Reporting Errors: A Guide for Pharmacists and Technicians

ASHP Midyear 2025

Overview and Burden of Migraine

Mastering Hypertrophic Cardiomyopathy: Cutting-Edge Therapies for Better Outcomes

The Impact and Role of Pharmacists in the Management of Specialty Therapies

Exploring Advances in the Management of DOAC-Associated Bleeding With Reversal Agents: Role of the Health-System Pharmacists

Multidisciplinary Perspectives and Patient-Centered Approaches in Newly Diagnosed Multiple Myeloma

Implementing Updated RSV Vaccination Recommendations for Older Adults: Introduction and Disease Burden (Part 1)

Implementing Updated RSV Vaccination Recommendations for Older Adults: Considerations for the Pharmacist (Pharmacy Technician Credit)

Advancing Acute Pain Care: Breakthrough Non-Opioid Therapies and the Pharmacist's Critical Role

Driving Better Outcomes in Hypertrophic Cardiomyopathy: A Managed Care Imperative

Expanding Access to Antibody-Based Regimens in Relapsed/Refractory Multiple Myeloma

Advancing Care in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: Optimizing Outcomes With Emerging Therapies

Advances and Innovations in Hypertrophic Cardiomyopathy Management: A Focus on New and Emerging Therapies

Navigating the Complexity of Migraine: A Multimodal Approach to Acute Treatment

Iron Deficiency Anemia Treatment Considerations in Women’s Health

The Changing Paradigm in Pain Management and Supporting Access to Novel Therapies

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacist Credit)

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmacy Technician Credit)

Bridging Knowledge Gaps in HR+/HER2– Early-Stage Breast Cancer

Understanding Type 2 Inflammation and Its Role Across Various Immune-Related Diseases

Expert Insights on the Horizon of HER2-Directed Therapy

Breaking Barriers in Asthma Care: Exploring the Role of Type 2 Inflammation and Biologic Therapies

Type 2 Inflammation in Focus: Advancing Pediatric Atopic Dermatitis Care With Biologic Therapies

Updated Guidance and Managed Care Strategies to Optimize Care in EGFR Mutated NSCLC

Advancing Pharmacist Expertise in R/R FL: Navigating Novel Therapies and Optimizing Patient Outcomes

Paroxysmal Nocturnal Hemoglobinuria: Managed Care Strategies to Mitigate Burden and Enhance Outcomes

The Pharmacist's Role in Palliative and End of Life Symptom Management

Opioids, Pain Management, and Substance Use Disorder: A Practical Overview

The Evolving Strategies for Managing nAMD and DME: Empowering Managed Care Decisions for Improved Patient Outcomes

Innovations in Diabetes Technology: A New Era of Patient Choice and Opportunities for Pharmacists to Support Insulin Pump Management

Addressing the Unmet Needs in the Management of Myasthenia Gravis: The Role of New and Emerging Therapies

Harnessing the Potential of SGLT2 Inhibitors in Cardiorenal Metabolic Health: Strategies for Long-term Care and Consultant Pharmacists

Transforming Small Cell Lung Cancer Management With DLL3-Targeted Therapies

Charting the Course: The Pharmacist's Role in Safeguarding Patients From Immune-Related Adverse Events

The Evolving Treatment Landscape of Migraine

The Role of the Pharmacist Migraine Management

Guiding Bispecific Antibody Use in Non-Hodgkin Lymphoma: Integrating Evidence and Enhancing Care

Strategies to Reduce Challenges in the Management of Chronic Rhinosinusitis with Nasal Polyps: The Role of Biologic Therapy

Navigating the New Wave in Targeted Therapies for Acute Myeloid Leukemia: A Focus on IDH and FLT3 Mutations

Combating Opioid Overdoses: The Impact of Pharmacist-led Counseling and Dispensing of Opioid Reversal Agents

New and Approved: FDA’s 2024 Drug Lineup